Dianthus Therapeutics To Participate in the 8th Annual Evercore Healthcare Conference
Dianthus Therapeutics (Nasdaq: DNTH) will participate in the 8th Annual Evercore Healthcare Conference in Coral Gables, Florida. Marino Garcia, CEO, will join a fireside chat on December 2, 2025 at 2:35 p.m. ET and will hold one-on-one investor meetings.
A live webcast of the presentation may be accessed via the News and Events page in the Investors section of the Dianthus Therapeutics website.
Dianthus Therapeutics (Nasdaq: DNTH) parteciperà alla 8ª Conferenza Annual Evercore Healthcare a Coral Gables, in Florida. Marino Garcia, CEO, parteciperà a una chiacchierata informale al caminetto il 2 dicembre 2025 alle 14:35 ET e terrà incontri individuali con gli investitori.
È possibile accedere a una trasmissione in diretta della presentazione tramite la pagina Notizie ed Eventi nella sezione Investitori del sito web di Dianthus Therapeutics.
Dianthus Therapeutics (Nasdaq: DNTH) participará en la 8ª Conferencia Anual Evercore Healthcare en Coral Gables, Florida. Marino Garcia, CEO, se unirá a una charla junto a la chimenea el 2 de diciembre de 2025 a las 14:35 ET y realizará reuniones individuales con inversores.
Una transmisión en vivo de la presentación puede verse a través de la página News and Events en la sección de Inversores del sitio web de Dianthus Therapeutics.
Dianthus Therapeutics (Nasdaq: DNTH)은(는) 제8회 Evercore 헬스케어 컨퍼런스에 코랄 게이블스, 플로리다에서 참가합니다. Marino Garcia CEO가 2025년 12월 2일 동부 표준시 14:35에 열리는 파이어사이드 챗에 참여하고 투자자와의 1:1 미팅을 개최합니다.
발표의 실시간 생중계는 Dianthus Therapeutics 웹사이트의 투자자 섹션 내 뉴스와 이벤트 페이지에서 시청할 수 있습니다.
Dianthus Therapeutics (Nasdaq: DNTH) participera à la 8e conférence annuelle Evercore Healthcare à Coral Gables, en Floride. Marino Garcia, CEO, participera à une discussion au coin du feu le 2 décembre 2025 à 14h35 HE et tiendra des réunions investisseurs en tête-à-tête.
Une retransmission en direct de la présentation peut être visionnée via la page News and Events dans la section Investisseurs du site Dianthus Therapeutics.
Dianthus Therapeutics (Nasdaq: DNTH) nimmt an der 8th Annual Evercore Healthcare Conference in Coral Gables, Florida, teil. Marino Garcia, CEO, wird an einem Fireside-Chat am 2. Dezember 2025 um 14:35 Uhr ET teilnehmen und Einzelgespräche mit Investoren führen.
Eine Live-Übertragung der Präsentation kann über die Seite News and Events im Bereich Investoren der Dianthus Therapeutics-Website aufgerufen werden.
Dianthus Therapeutics (Nasdaq: DNTH) ستشارك في المؤتمر الطبي Evercore Healthcare الثامن في كورال ميبلس، فلوريدا. سينضم مارينو غارسيا، الرئيس التنفيذي، إلى حوار بجانب المدفأة في 2 ديسمبر 2025 الساعة 2:35 مساءً بتوقيت شرق الولايات المتحدة وسيعقد اجتماعات فردية مع المستثمرين.
يمكن الوصول إلى البث المباشر للعرض عبر صفحة الأخبار والفعاليات في قسم المستثمرين على موقع Dianthus Therapeutics.
- None.
- None.
NEW YORK and WALTHAM, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced the Company’s participation in the 8th Annual Evercore Healthcare Conference in Coral Gables, Florida. Marino Garcia, CEO of Dianthus Therapeutics, will participate in a fireside chat on Tuesday, December 2, 2025 at 2:35 p.m. ET and will host one-on-one meetings with investors.
A webcast of this presentation may be accessed under “News and Events” in the Investors section of the Dianthus Therapeutics website.
About Dianthus Therapeutics
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases. Based in New York City and Waltham, Mass., Dianthus is comprised of an experienced team of biotech and pharma executives who aim to deliver transformative medicines for people living with severe autoimmune and inflammatory diseases.
To learn more, please visit www.dianthustx.com and follow us on LinkedIn.
Contact
Jennifer Davis Ruff
Dianthus Therapeutics
jdavisruff@dianthustx.com